Aspirin and hormone therapy for prostate cancer [12]

New England Journal of Medicine

Volumn 357, Issue 26, 2007, Pages 2737-2738

  D'Amico, Anthony V ^a   Kantoff, Philip W ^a   Chen, Ming Hui ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANDROGEN; ATORVASTATIN; FLUTAMIDE; GONADORELIN AGONIST;

CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG FATALITY; DRUG WITHDRAWAL; HUMAN; INTERMETHOD COMPARISON; LETTER; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 37549063053     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0706698     Document Type: Letter

References (5)

1. Freeland GR, Northington RS, Hedrich DA, Walker BR. Hepatic safety of two analgesics used over the counter: ibuprofen and aspirin. Clin Pharmacol Ther 1988;43:473-9.
2. Kehinde EO, Eldeen AS, Ayesha A, Anim JT, Memon A, Al-Sulaiman SM. Effect of castration on acetyl salicylic acid metabolism in rabbits. Urology 2003;61:651-5.
3. D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A, Kantoff PW. 6-Month androgen suppression plus radiation therapy vs. radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA 2004;292:821-7.
4. Agresti A. Categorical data analysis. 2nd ed. Hoboken, NJ: Wiley-Interscience, 2002:165-210.
5. Semiparametric proportional hazards regression with fixed covariates. In: Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. 2nd ed. New York: Springer, 2003:243-93.